Page results
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
This is information for women who have been given a diagnosis of adenomyosis.
-
This service provides a tertiary level, second opinion service, specialising in the diagnostic assessment and treatment of complex speech sound disorders. The team has particular expertise in Childhood Apraxia of Speech (CAS).
-
This information page aims to answer some of the questions you may have about receiving chimeric antigen receptor (CAR) T-cell therapy at University College London Hospitals NHS Foundation Trust (UCLH).
-
Information about clinic-based after-care following treatment for childhood or teenage cancer at UCLH.
-
Bones marrow harvest patient information page.
-
Information about the Integrative Talking Therapies service at the Royal London Hospital for Integrated Medicine.
-
The first UK trial to test the benefits of proton beam therapy for certain patients with breast cancer has launched at UCLH.
-
This page provides information about ERCP (Endoscopic Retrograde Cholangiopancreatography) procedure.
-
The Neuroimmunology and CSF Laboratory at the Institute of Neurology, UCLH is a UKAS accredited medical laboratory No. 8045.
File results
-
FOI/2023/0767 - Insomnia treatment pathways
-
FOI/2023/0768 - Issues/ problems with Electronic Patient Records (EPR)
-
FOI/2023/0769 - Patients with Inflammatory Bowel Disease/ Small Intestinal Bacterial Overgrowth (SIBO)
-
FOI/2023/0776 - Electronic Patients Records System (EPRS)
-
FOI/2023/0777 - Number of patients treated for scurvy and ricketts
-
FOI/2023/0787 - HIMSS INFRAM assessment/ digital strategy
-
FOI/2023/0788 - Networking/ WiFi/ telephony hardware/ unified communications refresh
-
FOI/2023/0792 - Bank and agency strategy for the ICB
-
FOI/2023/0794 - Pandas/ PANS/ immune mediated neuro behaviour conditions
-
FOI/2023/0799 - Bronchiectasis pathway